Fair value measurement (Tables)

3 Months Ended

Mar. 30, 2025

Fair Value Disclosures [Abstract]

Financial assets and liabilities carried at fair value measured on recurring basis

The following tables provide information regarding our financial assets and liabilities measured at fair value on a recurring basis as of March 30, 2025 and December 31, 2024:

	Total carrying  value at  March 30, 2025		Quoted prices in active markets (Level 1)		Significant other observable Inputs (Level 2)		Significant unobservable Inputs (Level 3)
Investments in marketable securities	$	36,379	$	36,379	$	—	$	—
Derivative assets	35,825		—		35,825		—
Derivative liabilities	28,543		—		28,543		—
Contingent consideration liabilities	47,426		—		—		47,426

	Total carrying value at December 31, 2024		Quoted prices in active markets (Level 1)		Significant other observable Inputs (Level 2)		Significant unobservable Inputs (Level 3)
Investments in marketable securities	$	39,559	$	39,559	$	—	$	—
Derivative assets	27,415		—		27,415		—
Derivative liabilities	13,584		—		13,584		—
Contingent consideration liabilities	49,277		—		—		49,277

Schedule of Valuation Techniques

The table below provides additional information regarding the valuation technique and inputs used in determining the fair value of our significant contingent consideration liabilities.

Contingent Consideration Liability	Valuation Technique	Unobservable Input
Revenue-based
	Monte Carlo simulation	Revenue volatility	18.9%
		Risk free rate	Cost of debt structure
		Projected year of payment	Prior to the end of 2026

Reconciliation of Changes in Level 3 Financial Liabilities Measured at Fair Value on Recurring Basis

The following table provides information regarding changes in our contingent consideration liabilities for the three months ended March 30, 2025:

	Contingent consideration
Balance – December 31, 2024	$	49,277
Payments	(56)
Revaluations	(1,795)
Balance – March 30, 2025	$	47,426